A Cole Eye Institute research team will study the role of inflammation in retinal regeneration in zebrafish, with support from a new four-year grant from the National Eye Institute.Read More
Numerous cancer treatments have been shown to have side effects such as ocular toxicities.
Cancer metastasis to the eye can manifest as ocular motility issues, blurry vision, and sunken or bulging eyes. Ophthalmologists can contribute to prompt diagnosis and treatment to improve a patient’s quality of life.
A JAMA Ophthalmology study reveals the pitfalls of using artificial intelligence tools like ChatGPT to generate ophthalmic research abstracts and references.
Minimally invasive glaucoma surgery (MIGS) isn’t just for mild to moderate conditions. It is safer and may be more effective than tube shunts in patients with uveitic and steroid-induced glaucoma.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Optical coherence tomography angiography (OCT-A) can be a useful adjunct in retina practices with or without fluorescein angiography. Here are five uses for the imaging technology in managing age-related macular degeneration (AMD) and diabetic retinopathy.
Leukocoria (white pupil) is the most common symptom of retinoblastoma, a rare eye cancer that affects only children under age 5.
A 1-year-old with posterior polymorphous corneal dystrophy is one of the youngest patients ever to have a bilateral cornea transplant via Descemet’s membrane endothelial keratoplasty (DMEK).
Topical losartan potentially can help reverse corneal scarring fibrosis caused by disease, injury and surgical complications. More clinical trials are needed to evaluate its efficacy and safety. The pioneering investigator, Steven E. Wilson, MD, offers guidance.
Stabilizing the volume of exudative fluid, including subretinal fluid, may help maximize anti-VEGF treatment outcomes for patients with nAMD.
Although anti-VEGF therapy is the current gold-standard treatment for retinal vein occlusion, not all patients respond to it. A study has found that volume of intraretinal fluid, among other factors detectable with optical coherence tomography, may help predict treatment response.